Epstein Secrets

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

ad to price-gouging and a lack of transparency." Adams To Take More Prominent Role In Administration's Pandemic Response. The New York Times (7/21, Stolberg, Weiland, 18.61M) reports Surgeon General Adams "is poised to take on a more prominent role" in the Administration's pandemic response. Dr. Adams "w

ree in 10 parents said they planned to vaccinate their children as soon as they could." In addition, "The survey found that public confidence in the Johnson & Johnson vaccine has plummeted since health authorities suspended using it for 10 days to examine possible links to a rare, dangerous blood dotting problem.

than six months ago." Foreign Health Officials Pause Distribution Of J&J Vaccines Made By Emergent. The New York Times (5/6, Al, Hamby, LaFraniere, Stolberg, 20.6M) reports that "quality-control problems" at Emergent BioSolutions' manufacturing plant in Baltimore, Maryland have led health officials in C

s-may- ready-early-2021/5478232002/> (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Modema and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guid

s Pandemic Response. The New York Times <https://www.nytimes.com/2020/07/21/us/politics/jerome-adams-surgeon-general-trump- coronavirus.html> (7/21, Stolberg, Weiland, 18.61M) reports Surgeon General Adams "is poised to take on a more prominent role" in the Administration's pandemic response. Dr. Adams "w

ication, 8.41M) also have reports. J&J Says It Should Have Enough Doses For More Than 20M By End Of March. The Hill (2/22, Sullivan, 5.69M) reports Johnson & Johnson said Monday that it "plans to have enough doses of its vaccine for more than 20 million Americans by the end of March" if its vaccine is authorized

bsite that the President "also expressed optimism, telling Americans: 'We will get through this, I promise you." The New York Times (2/22, Sanger, Stolberg, 20.6M) reports the President "urged the nation on Monday night to 'resist becoming numb to the sorrow' that the novel coronavirus had EFTA00148054

uccia, Subscription Publication, 8.41M), Politico (1/26, Cancryn, Roubein, 6.73M), and The Hill (1/26, Sullivan, Samuels, 5.69M) also have reports. Johnson & Johnson Expects To Report Vaccine Data Next Week. Reuters (1/26, Mishra, O'Donnell) reports that on Tuesday, Johnson & Johnson "said it expected to report

ditional doses. Those people, like several others, spoke on the condition of anonymity to describe internal matters." The New York Times (1/26, Al, Stolberg, Weiland, LaFraniere, 20.6M) says that while Biden "said the moves were `going to allow millions more Americans to get vaccinated sooner than previ

ew surge." Although the Times adds "experts aren't sure why vaccination rates have begun falling, or whether vaccine hesitancy, an issue before the Johnson & Johnson pause, is entirely to blame," Lilia Luciano reported on the CBS Weekend NewsVi (4/25, lead story, 2:30, Duncan, 1.24M) that a new CBS News poll "fin

told ABC News on Sunday such a move was 'something that certainly is going to be actively considered." Meanwhile, the New York Times (4/25, Rogers, Stolberg, 20.6M) states that the Administration's "abrupt shift...came after" National Security Adviser Sullivan "held a call earlier in the day with Ajit D

ng plant in Baltimore, Maryland have led health officials in Canada, the European Union, and South Africa "to pause the distribution of millions of Johnson & Johnson doses, as the troubles of a politically connected U.S. contractor ripple across the world." Officials from all three governments "said there was no

than six months ago." Foreign Health Officials Pause Distribution Of J&J Vaccines Made By Emergent. The New York Times (5/6, Al, Hamby, LaFraniere, Stolberg, 20.6M) reports that "quality-control problems" at Emergent BioSolutions' manufacturing plant in Baltimore, Maryland have led health officials in C

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

ad to price-gouging and a lack of transparency." Adams To Take More Prominent Role In Administration's Pandemic Response. The New York Times (7/21, Stolberg, Weiland, 18.61M) reports Surgeon General Adams "is poised to take on a more prominent role" in the Administration's pandemic response. Dr. Adams "

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

ad to price-gouging and a lack of transparency." Adams To Take More Prominent Role In Administration's Pandemic Response. The New York Times (7/21, Stolberg, Weiland, 18.61M) reports Surgeon General Adams "is poised to take on a more prominent role" in the Administration's pandemic response. Dr. Adams "